Assessing sedo-analgesic effects: A comparative analysis of ketamine vs dexmedetomidine infusion.

To compare the sedo-analgesic effect of ketamine & dexmedetomidine infusion in ultrasound guided supraclavicular nerve block with 0.5% ropivacaine â?? A prospective randomized clinical study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055164

Enrollment

Registered

2023-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: sedo-analgesic effect of ketamine with ropivacaine: patient will be randomly allocated in two groups .Group K (ketamine infusion ) and Group D (dexmedetomidine infusion). Group K - wil

Eligibility

Inclusion criteria

Inclusion criteria: Patient of ASA-I & ASA-II physical status.Patient between 18-60 years of age of either gender.Patient with Mallampati Class I-II.Patient posted for upper limb surgery under supraclavicular nerve block.Patient willing to participate

Exclusion criteria

Exclusion criteria: Patient refusal to participate. Patients with ASA physical status III and above Patient aged less than 18 years and more than 60 years Patient allergic to study drugs.

Design outcomes

Primary

Measure	Time frame
To access analgesia using VAS score up to 24 hours post operatively. Timepoint: 24 hours	—

Secondary

Measure	Time frame
To access peri-operative sedation using modified Ramsay sedation scoring system. Timepoint: 5 hours	—

Countries

India

Contacts

Public ContactDr Mumtaz Hussain

Indira Gandhi institute of medical sciences, Sheikhpura,Patna

drhussain72@yahoo.co.in8544413239

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026